EXACT SCIENCES CORP's ticker is and the CUSIP is 30063PAC9. A total of 65 filers reported holding EXACT SCIENCES CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,747,000 | -98.6% | 3,176,000 | -98.7% | 0.03% | -98.6% |
| Q4 2022 | $194,720,271 | +11.0% | 247,458,000 | -9.2% | 2.04% | +27.3% |
| Q3 2022 | $175,483,000 | -5.3% | 272,458,000 | +1.4% | 1.60% | -5.7% |
| Q2 2022 | $185,259,000 | -30.0% | 268,802,000 | -9.9% | 1.70% | +2.6% |
| Q1 2022 | $264,595,000 | -0.8% | 298,402,000 | +8.6% | 1.66% | +1.7% |
| Q4 2021 | $266,837,000 | -11.1% | 274,802,000 | -1.3% | 1.63% | -7.5% |
| Q3 2021 | $300,104,000 | -12.0% | 278,327,000 | +1.3% | 1.76% | -2.0% |
| Q2 2021 | $341,037,000 | -4.5% | 274,777,000 | -0.4% | 1.80% | -31.9% |
| Q1 2021 | $356,932,000 | -4.1% | 275,977,000 | -3.2% | 2.64% | -5.0% |
| Q4 2020 | $372,233,000 | +17.0% | 284,990,000 | -2.7% | 2.78% | -27.5% |
| Q3 2020 | $318,182,000 | -17.1% | 292,990,000 | -26.8% | 3.84% | -38.2% |
| Q2 2020 | $383,650,000 | +20.7% | 400,190,000 | -0.9% | 6.21% | +10.0% |
| Q1 2020 | $317,894,000 | – | 404,000,000 | – | 5.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 178,534,000 | $194,095,000 | 8.00% |
| LINDEN ADVISORS LP | 292,990,000 | $318,182,000 | 3.84% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,475,000 | $48,022,000 | 1.54% |
| Cheyne Capital Management (UK) LLP | 2,350,000 | $2,546,000 | 1.26% |
| DeepCurrents Investment Group LLC | 28,948,000 | $31,403,000 | 1.06% |
| Nicholas Investment Partners, LP | 6,965,000 | $7,521,000 | 0.81% |
| Lombard Odier Asset Management (Europe) Ltd | 11,518,000 | $12,499,000 | 0.74% |
| AQR Arbitrage LLC | 18,300,000 | $19,851,000 | 0.72% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,648,000 | $30,001,000 | 0.66% |
| BlueCrest Capital Management Ltd | 16,086,000 | $17,424,000 | 0.64% |